Utah Medical Products, Inc.
UTMD
$63.12
$0.250.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.83% | -12.35% | -16.64% | -19.92% | -18.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.83% | -12.35% | -16.64% | -19.92% | -18.56% |
| Cost of Revenue | -1.43% | -8.73% | -13.27% | -18.55% | -16.97% |
| Gross Profit | -8.88% | -14.89% | -18.99% | -20.88% | -19.62% |
| SG&A Expenses | 12.78% | 3.24% | -15.10% | -23.92% | -31.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.32% | -5.88% | -14.24% | -19.83% | -20.81% |
| Operating Income | -18.87% | -22.60% | -20.60% | -20.08% | -14.68% |
| Income Before Tax | -16.03% | -19.71% | -17.65% | -19.76% | -16.36% |
| Income Tax Expenses | -3.59% | 1.63% | -7.68% | -14.39% | -15.23% |
| Earnings from Continuing Operations | -18.65% | -23.83% | -19.68% | -20.87% | -16.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.65% | -23.83% | -19.68% | -20.87% | -16.60% |
| EBIT | -18.87% | -22.60% | -20.60% | -20.08% | -14.68% |
| EBITDA | -15.17% | -20.01% | -22.42% | -25.82% | -25.15% |
| EPS Basic | -11.94% | -17.33% | -13.76% | -16.34% | -13.77% |
| Normalized Basic EPS | -11.52% | -16.26% | -14.59% | -14.71% | -10.01% |
| EPS Diluted | -11.95% | -17.33% | -13.67% | -16.18% | -13.58% |
| Normalized Diluted EPS | -11.52% | -16.26% | -14.54% | -14.60% | -9.84% |
| Average Basic Shares Outstanding | -7.52% | -7.77% | -6.86% | -5.51% | -3.46% |
| Average Diluted Shares Outstanding | -7.52% | -7.77% | -6.92% | -5.64% | -3.64% |
| Dividend Per Share | 1.66% | 1.67% | 1.67% | 1.68% | 1.69% |
| Payout Ratio | 0.15% | 0.24% | 0.19% | 0.23% | 0.19% |